Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Press Statements

      Prothena Announces Global Neuroscience R&D Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

      Press Statements
      Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan...

      Roche’s TECENTRIQ plus chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous...

      Clinical Trials
      Roche announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab)...

      Tasigna drug to treat children with rare form of leukemia receives FDA approval: Novartis

      FDA Approvals
      Novartis announced that the US FDA expanded the indication for Tasigna  (nilotinib) to include treatment of first- and second-line pediatric patients one year of...

      GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus

      Clinical Trials
      GSK announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE)....

      Praluent extensively reduces risk of cardiovascular events in high-risk patients, and was associated with lower death rate 

      Press Statements
      Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse...

      Business Finland provides €3 Million Loan to Forendo Pharma for Developing Novel Treatments for Endometriosis

      Press Statements
      Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a €3 million R&D loan...

      Italian pharmaceutical R & D excellence presented at the 33rd Congress of the European Association of Urology

      Press Statements
      Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative anti-cancer cell-directed paclitaxel-hyaluronan bioconjugate...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.